MMR deficiency in endometrial cancer may be best assessed using immunohistochemical (IHC) staining for the four major DNA mismatch repair proteins (MLH1, MSH2, MSH6 and PMS2), which appears to outperform the classical microsatellite instability testing [53]. The gene discussed is PMS2; the disease is endometrial cancer.